Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-20

Clinical Trial Update: Circulating Tumor DNA in Stage I, II, and III Germ-Cell Tumors [NA]

View source ↗

Summary

A clinical trial evaluating circulating tumor DNA in stage I-III germ-cell tumors, currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Indiana University | Conditions: Germ Cell Cancer Metastatic | NA | Status: NOT_YET_RECRUITING